Hosted on MSN
Syncom Formulations (India) Ltd Reports Stellar Growth in Q4 and FY 2024-25 Results; Profit After Tax Surges by 139%
Syncom Formulations (India) Limited, a leading name in the Indian pharmaceutical sector specialising in high-quality pharmaceutical formulations, has announced an outstanding performance for the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
India announces its annual budget on Sunday, with the Defence Ministry seeking higher military spending, industry urging cuts in tax rates on market transactions and customs duties, and the government ...
Review the current valuation for Syncom Formulation (India) Ltd (SYNCOMF:XNSE) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results